The Patent Finder

Syntrix Biosystems Inc.

19 patents currently held · Updated Nov 21, 2026
3 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded under 2 name spellings.

2
Ending by 2030
Feb 2030
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Aug 18, 2027
    The maintenance fee for Method for treating cancer using dual antagonists of CXCR1 and CXCR2 (US 10,561,676) comes due Aug 18, 2027. Unpaid by Feb 18, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

  • 1 term has ended since Aug 23, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US RE47,415Pyrimidinecarboxamides as CXCR2 Modulators
In force
 · Low confidence
In forceLow confidence
US RE47,267Pyridinecarboxamides as CXCR2 modulators
In force
 · USPTO record
In forceUSPTO record
US 9,000,142Photocleavable Sense-Antisense Complex
In force
 · High confidence
In forceHigh confidence
US RE47,740Aminopyridinecarboxamides as CXCR2 modulators
In force
 · USPTO record
In forceUSPTO record
US RE48,547Aminopyrimidinecarboxamides as CXCR2 Modulators
In force
 · Low confidence
In forceLow confidence
US 9,717,700Methods for overcoming resistance to tramadol
In force
 · USPTO record
In forceUSPTO record
US 9,717,701Compositions for overcoming resistance to tramadol
In force
 · USPTO record
In forceUSPTO record
US 9,808,432Methods for overcoming resistance to tramadol
In force
 · USPTO record
In forceUSPTO record
US 10,702,485Compositions and methods for overcoming resistance to tramadol
In force
 · USPTO record
In forceUSPTO record
US 8,969,365Thiopyrimidinecarboxamides as CXCR1/2 Modulators
In force
 · High confidence
In forceHigh confidence
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
Also on record, not counted in the 19: 3 patents in force now held by others · 6 ended at full term · 4 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

6 no status recorded

Showing 1 to 6 of 6, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.

ApplicationFiledStatus
15/662,189Jul 27, 2017No status recorded
15/662,160Jul 27, 2017No status recorded
13/905,044May 29, 2013No status recorded
12/325,126Nov 28, 2008No status recorded
11/924,250Oct 25, 2007No status recorded
11/834,533Aug 6, 2007No status recorded
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited